John Leaman | Chief Financial & Business Officer |
Adrian Adams | Chairman & CEO |
Leonard Paolillo | Chief Commercial Officer |
Ken Cacciatore | Cowen |
Good morning, ladies and gentlemen, and welcome to Impel Pharmaceuticals Third Quarter 2022 Earnings and Business Update Conference Call. At this time, all participants are in a listen-only mode. Later in this call a question-and-answer session will be conducted and instruction on how to participate will be given at that time.
As a reminder, today's conference call is being recorded. And now, I would like to turn the conference over to Impel's Chief Financial and Business Officer, Dr.